
    
      Adjuvant Gemcitabine Versus Gemcitabine With TS-1 based Chemoradiation in Pancreatic
      Adenocarcinoma With R1 Resection and/or Positive Lymph Nodes after curative resection: a
      randomized phase II study.
    
  